Home » Topics » Regulatory

Regulatory
RSS

FDA grants marketing approval to Acorda's Ampyra to improve walking in MS patients

Jan. 25, 2010

Daiichi granted Japanese approval to manufacture and market Rezaltas for hypertension

Jan. 21, 2010

Shionogi receives marketing approval for peramivir in Japan

Jan. 15, 2010

BioMarin's amifampridine phosphate approved in the EU for LEMS

Jan. 7, 2010

Novartis' Onbrez Breezhaler approved in E.U. for patients with COPD

Dec. 4, 2009

Kalbitor approved in U.S. for hereditary angioedema

Dec. 3, 2009

FDA approves Cymbalta for maintenance treatment of GAD

Dec. 1, 2009

Angiox approved in E.U. for additional indication

Dec. 1, 2009

France grants marketing authorization to Sanofi's Panenza influenza vaccine

Nov. 18, 2009

FDA approves Lysteda for the treatment of menorrhagia

Nov. 17, 2009

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...